Clinical Trial Update: A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describing mesothelin-targeted CAR T-cell therapy in esophagogastric and mesothelin-expressing tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophagogastric Adenocarcinoma

Drugs mentioned

• Mesothelin-targeted CAR T-cell therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mesothelin Positive, Mesothelin-Expressing Tumors | Phase 1 | Status: RECRUITING